Emergency Medical Research Journals

Emergency Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Diener HC et al. - The authors evaluated telmisartan 80 mg for migraine prophylaxis. Migraine patients (n = 95) with three to seven migraine attacks in 3 months were randomized, double-blind to telmisartan or placebo...The reduction in migraine days was 1.65 with telmisartan and 1.14 with placebo. Post hoc analyses adjusting for baseline and centre showed a 38% reduction in migraine days with telmisartan vs. 15% with placebo, and a borderline significant difference in responders. The incidence of adverse events was similar between treatments. This study indicates that telmisartan might be effective in migraine prophylaxis.

Today in Neurology/Neurosurgery...keeping you current

Does sumatriptan cross the blood-brain barrier in animals and man?
The Journal of Headache and Pain, 12/16/09

Prothrombin Complex Concentrates for Oral Anticoagulant Therapy-Related Intracranial Hemorrhage: A Review of the Literature
Neurocritical Care , 12/15/09

CSF Neutrophils Are Implicated in the Development of Vasospasm in Subarachnoid Hemorrhage
Neurocritical Care , 12/15/09

Today in Pain Management...keeping you current

Does sumatriptan cross the blood-brain barrier in animals and man?
The Journal of Headache and Pain, 12/16/09

Headache patients in the emergency department of a Greek tertiary care hospital
The Journal of Headache and Pain, 12/15/09

Acute Low Back Pain with Radiculopathy: A Double-Blind, Randomized, Placebo-Controlled Study
Photomedicine and Laser Surgery, 12/14/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address